HPCM
GILD icon

High Pointe Capital Management’s Gilead Sciences GILD Stock Holding History

High Pointe Capital Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-17,250
Closed -$1.43M – 173
2014
Q2 		$1.43M Hold
17,250
– – 0.52% 95
2014
Q1 		$1.22M Hold
17,250
– – 0.47% 97
2013
Q4 		$1.29M Sell
17,250
-30,100
-64% -$2.1M 0.51% 96
2013
Q3 		$2.98M Sell
47,350
-10,400
-18% -$622K 1.2% 12
2013
Q2 		$2.96M Buy
+57,750
New +$3.01M 1.3% 9

Other funds holding GILD

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

High Pointe Capital Management's GILD Position: Q3 2014 in Review

High Pointe Capital Management sold out of Gilead Sciences (GILD) in Q3 2014, closing a stake of 17,250 shares — an estimated $1.43M sold.

High Pointe Capital Management first reported a position in GILD in Q2 2013 and held it in 5 quarters. The position peaked at $2.98M in Q3 2013. 1,326 funds tracked by Wall St. Rank hold GILD as of Q3 2014.

  • High Pointe Capital Management reported no remaining Gilead Sciences position as of Q3 2014 after selling out during the quarter.
  • High Pointe Capital Management sold 17,250 Gilead Sciences shares in Q3 2014, an estimated $1.43M.
  • High Pointe Capital Management first reported a position in Gilead Sciences in Q2 2013 and held it in 5 quarters.
  • High Pointe Capital Management's Gilead Sciences position peaked at $2.98M in Q3 2013.
  • 1,326 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2014.

Based on High Pointe Capital Management's 13F filing for Q3 2014, filed 30 Oct 2014.